Adverse Events After Carbon-Ion Radiotherapy (CIRT) for Hepatocellular Carcinoma and Risk Factors for Biliary Stricture After CIRT: A Retrospective Study
- PMID: 40805237
- PMCID: PMC12346405
- DOI: 10.3390/cancers17152542
Adverse Events After Carbon-Ion Radiotherapy (CIRT) for Hepatocellular Carcinoma and Risk Factors for Biliary Stricture After CIRT: A Retrospective Study
Abstract
Background/Objectives: This study investigated the timing of adverse events (AEs) after carbon-ion radiotherapy (CIRT) for hepatocellular carcinoma (HCC) and identified the risk factors for biliary stricture post CIRT. Methods: This retrospective study included 103 patients with HCC who had undergone CIRT (60 Gy/4 fractions). The onset, frequency, and grade of AEs after CIRT were analyzed. HCC was classified into perihilar and distal types to assess the frequency of biliary stricture, and the risk factors for biliary stricture were investigated. Results: AEs after CIRT were more frequent in patients with liver dysfunction, skin redness/dermatitis, and pigmentation. Biliary stricture occurred long after CIRT (3.0-17.0 months). Most AEs were of grade 1-2. Grade ≥ 3 AEs included biliary stricture (2.9%) and radiation gastric ulcer (1.0%), whereas grade 5 AEs included biliary stricture (1.9%). Biliary stricture was exclusively observed in patients with perihilar-type HCC. Among patients with perihilar-type HCC, those having a tumor in the portal vein trunk branch area were more prone to biliary stricture than those with a tumor in the primary portal vein branch area (p = 0.0018), and all grade ≥ 3 biliary strictures (2.9%) were observed in the portal vein trunk branch area. Patients with perihilar-type HCC and biliary stricture were more likely to have macrovascular invasion (p = 0.0052) and previous local therapy targeting the perihilar region (p = 0.0371) than those without biliary stricture. Conclusions: This study reported the detailed data of AEs post CIRT for HCC and the risk factors for biliary stricture post CIRT.
Keywords: adverse events after carbon-ion radiotherapy; biliary stricture; carbon-ion radiotherapy; hepatocellular carcinoma.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
A Novel Treatment Strategy for Unresectable Locally Recurrent Rectal Cancer-Upfront Carbon-Ion Radiotherapy Followed by Surgical Resection of the Irradiated Intestines.Cancers (Basel). 2025 Jul 3;17(13):2230. doi: 10.3390/cancers17132230. Cancers (Basel). 2025. PMID: 40647528 Free PMC article.
-
Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma.Cochrane Database Syst Rev. 2015 Jan 9;1(1):CD010533. doi: 10.1002/14651858.CD010533.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2025 Mar 26;3:CD010533. doi: 10.1002/14651858.CD010533.pub3. PMID: 25572491 Free PMC article. Updated.
-
Carbon-Ion Radiotherapy as a Local Treatment Option for Hepatocellular Carcinoma With Child-Pugh Class B Cirrhosis.Adv Radiat Oncol. 2025 May 17;10(8):101812. doi: 10.1016/j.adro.2025.101812. eCollection 2025 Aug. Adv Radiat Oncol. 2025. PMID: 40607041 Free PMC article.
-
Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011650. doi: 10.1002/14651858.CD011650.pub2. Cochrane Database Syst Rev. 2017. PMID: 28351116 Free PMC article.
-
Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer).Cochrane Database Syst Rev. 2018 Jul 12;7(7):CD012556. doi: 10.1002/14651858.CD012556.pub2. Cochrane Database Syst Rev. 2018. PMID: 30001476 Free PMC article.
References
-
- Akinyemiju T., Abera S., Ahmed M., Alam N., Alemayohu M.A., Allen C., Al-Raddadi R., Alvis-Guzman N., Amoako Y., Artaman A., et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: Results from the Global Burden of Disease Study 2015. JAMA Oncol. 2017;3:1683–1691. doi: 10.1001/jamaoncol.2017.3055. - DOI - PMC - PubMed
-
- Okazaki S., Shibuya K., Shiba S., Okamoto M., Miyasaka Y., Osu N., Kawashima M., Kakizaki S., Araki K., Shirabe K. Carbon ion radiotherapy for patients with hepatocellular carcinoma in the caudate lobe carbon ion radiotherapy for hepatocellular carcinoma in caudate lobe. Hepatol. Res. 2021;51:303–312. doi: 10.1111/hepr.13606. - DOI - PubMed
LinkOut - more resources
Full Text Sources